Editorial: Osteoporosis in Rheumatic Diseases, What's New?

Front Med (Lausanne) · 2021 · PMC8677666 · PMID 34926536

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

There was a slight, non-significant osteo-metabolic improvement in the alendronate group compared to the denosumab group and, interestingly, the denosumab group had a positive trend in the RSMI index.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.